• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国参保成年人血糖控制中的种族和民族差异。

Racial and Ethnic Disparities in Glycemic Control Among Insured US Adults.

机构信息

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York.

Department of Medicine, Division of Endocrinology, Diabetes Research Center, Columbia University Irving Medical Center, New York, New York.

出版信息

JAMA Netw Open. 2023 Oct 2;6(10):e2336307. doi: 10.1001/jamanetworkopen.2023.36307.

DOI:10.1001/jamanetworkopen.2023.36307
PMID:37796503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10556965/
Abstract

IMPORTANCE

Poor access to care and lack of health insurance are important contributors to disparities in glycemic control. However expanding health insurance coverage may not be enough to fully address the high burden of poor glycemic control for some groups.

OBJECTIVE

To characterize racial and ethnic disparities in glycemic control among adults with private and public insurance in the US over a 15-year timeframe and to evaluate whether social, health care, and behavioral or health status factors attenuate estimates of disparities.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the National Health and Nutrition Examination Survey from 2003 to 2018. Participants included Hispanic or Latino, non-Hispanic Black, and non-Hispanic White adults aged 25 to 80 years with self-reported diabetes and health insurance. Data were analyzed from January 15 to August 23, 2023.

EXPOSURE

Participants self-identified as Hispanic or Latino, non-Hispanic Black, or non-Hispanic White.

MAIN OUTCOMES AND MEASURES

The main outcome, poor glycemic control, was defined as glycated hemoglobin A1c (HbA1c) of 7.0% or greater. Information about social (education, food security, and nativity), health care (insurance type, routine place for health care, insurance gap in past year, and use of diabetes medications), and behavioral or health status (years with diabetes, waist circumference, and smoking) factors were collected via questionnaires.

RESULTS

A total of 4070 individuals (weighted mean [SE] age, 61.4 [0.27] years; 1970 [weighted proportion, 49.3%] were women) were included, representing 16 337 362 US adults, including 1146 Hispanic or Latino individuals (weighted proportion, 13.2%), 1196 non-Hispanic Black individuals (weighted proportion, 15.7%), and 1728 non-Hispanic White individuals (weighted proportion, 71.1%). In models adjusted for age, sex, and survey year, Hispanic or Latino and non-Hispanic Black individuals had significantly higher odds of poor glycemic control than non-Hispanic White individuals (Hispanic or Latino: odds ratio [OR], 1.46; 95% CI, 1.16-1.83; Black: OR, 1.28; 95% CI, 1.04-1.57). There was some attenuation after adjustment for social factors, especially food security (Hispanic or Latino: OR, 1.39; 95% CI, 1.08-1.81); Black: OR, 1.39; 95% CI, 1.08-1.81). However, accounting for health care and behavioral or health status factors increased disparities, especially for Hispanic or Latino individuals (OR, 1.63; 95% CI, 1.24-2.16), with racial and ethnic disparities persisting even among those with private insurance (OR, 1.66; 95% CI, 1.10-2.52).

CONCLUSIONS AND RELEVANCE

In this cross-sectional study of insured adults with diabetes in the US, disparities in poor glycemic control persisted despite adjustment for social, health care, and behavioral factors. Research is needed to identify the barriers contributing to poor control even in populations with access to care.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d141/10556965/fe3375e5aefa/jamanetwopen-e2336307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d141/10556965/fe3375e5aefa/jamanetwopen-e2336307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d141/10556965/fe3375e5aefa/jamanetwopen-e2336307-g001.jpg
摘要

重要性:医疗保健获取不足和缺乏健康保险是导致血糖控制差异的重要因素。然而,扩大健康保险覆盖范围可能不足以完全解决某些群体血糖控制不佳的高负担。

目的:在 15 年的时间内,描述美国拥有私人和公共保险的成年人在血糖控制方面的种族和族裔差异,并评估社会、医疗保健以及行为或健康状况因素是否会降低差异估计值。

设计、地点和参与者:这项横断面研究使用了 2003 年至 2018 年全国健康和营养调查的数据。参与者包括 25 岁至 80 岁有自我报告糖尿病和健康保险的西班牙裔或拉丁裔、非西班牙裔黑人和非西班牙裔白人成年人。数据分析于 2023 年 1 月 15 日至 8 月 23 日进行。

暴露:参与者自我认定为西班牙裔或拉丁裔、非西班牙裔黑人和非西班牙裔白人。

主要结果和措施:主要结果是血糖控制不佳,定义为糖化血红蛋白 A1c(HbA1c)大于或等于 7.0%。通过问卷收集了有关社会(教育、食品安全和出生地)、医疗保健(保险类型、常规医疗保健场所、去年保险缺口以及使用糖尿病药物)以及行为或健康状况(糖尿病患病年限、腰围和吸烟状况)的信息。

结果:共有 4070 人(加权平均[SE]年龄为 61.4[0.27]岁;1970 人[加权比例为 49.3%]为女性)被纳入研究,代表了 16337362 名美国成年人,其中包括 1146 名西班牙裔或拉丁裔个体(加权比例为 13.2%)、1196 名非西班牙裔黑人个体(加权比例为 15.7%)和 1728 名非西班牙裔白人个体(加权比例为 71.1%)。在调整年龄、性别和调查年份的模型中,西班牙裔或拉丁裔和非西班牙裔黑人个体的血糖控制不佳的可能性显著高于非西班牙裔白人个体(西班牙裔或拉丁裔:比值比[OR],1.46;95%置信区间[CI],1.16-1.83;黑人:OR,1.28;95%CI,1.04-1.57)。在调整社会因素后,这种差异有所减弱,尤其是在食品安全方面(西班牙裔或拉丁裔:OR,1.39;95%CI,1.08-1.81;黑人:OR,1.39;95%CI,1.08-1.81)。然而,考虑到医疗保健和行为或健康状况因素会增加差异,尤其是对于西班牙裔或拉丁裔个体(OR,1.63;95%CI,1.24-2.16),即使在拥有私人保险的人群中,种族和族裔差异仍然存在(OR,1.66;95%CI,1.10-2.52)。

结论和相关性:在这项对美国有保险的糖尿病成年患者的横断面研究中,尽管调整了社会、医疗保健和行为因素,但血糖控制不佳的差异仍然存在。需要研究以确定导致控制不佳的障碍,即使在有医疗保健机会的人群中也是如此。

相似文献

1
Racial and Ethnic Disparities in Glycemic Control Among Insured US Adults.美国参保成年人血糖控制中的种族和民族差异。
JAMA Netw Open. 2023 Oct 2;6(10):e2336307. doi: 10.1001/jamanetworkopen.2023.36307.
2
Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin, 1988-2020.美国成人糖尿病患者使用胰岛素的血糖控制和严重高血糖趋势及差异,1988-2020 年。
JAMA Netw Open. 2022 Dec 1;5(12):e2247656. doi: 10.1001/jamanetworkopen.2022.47656.
3
National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020.1999 年至 2020 年,动脉粥样硬化性心血管疾病成人患者接受推荐治疗的种族和民族差异的国家趋势。
JAMA Netw Open. 2023 Dec 1;6(12):e2345964. doi: 10.1001/jamanetworkopen.2023.45964.
4
Changes in Racial and Ethnic Disparities in Access to Care and Health Among US Adults at Age 65 Years.美国 65 岁成年人在获得医疗保健和健康方面的种族和民族差异的变化。
JAMA Intern Med. 2021 Sep 1;181(9):1207-1215. doi: 10.1001/jamainternmed.2021.3922.
5
Trends in Racial and Ethnic Disparities in Barriers to Timely Medical Care Among Adults in the US, 1999 to 2018.1999 年至 2018 年美国成年人及时获得医疗服务障碍的种族和民族差异趋势。
JAMA Health Forum. 2022 Oct 7;3(10):e223856. doi: 10.1001/jamahealthforum.2022.3856.
6
Evaluation of Temporal Trends in Racial and Ethnic Disparities in Sleep Duration Among US Adults, 2004-2018.2004 - 2018年美国成年人睡眠时长的种族和民族差异的时间趋势评估
JAMA Netw Open. 2022 Apr 1;5(4):e226385. doi: 10.1001/jamanetworkopen.2022.6385.
7
Racial and ethnic differences in uncontrolled diabetes mellitus among adults taking antidiabetic medication.服用抗糖尿病药物的成年人中未控制的糖尿病的种族和民族差异。
Prim Care Diabetes. 2024 Jun;18(3):368-373. doi: 10.1016/j.pcd.2024.02.004. Epub 2024 Feb 29.
8
Trends in Poor Health Indicators Among Black and Hispanic Middle-aged and Older Adults in the United States, 1999-2018.美国黑人和西班牙裔中老年人群不良健康指标的变化趋势,1999-2018 年。
JAMA Netw Open. 2020 Nov 2;3(11):e2025134. doi: 10.1001/jamanetworkopen.2020.25134.
9
Racial and Ethnic Disparities in Geographic Access to Autism Resources Across the US.美国各地自闭症资源获取的地理分布存在种族和民族差异。
JAMA Netw Open. 2023 Jan 3;6(1):e2251182. doi: 10.1001/jamanetworkopen.2022.51182.
10
Changes in racial and ethnic disparities in glucose-lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005-2018.美国糖尿病患者中降血糖药物利用和糖化血红蛋白 A1c 的种族和民族差异的变化:2005-2018 年。
Diabetes Obes Metab. 2023 Feb;25(2):516-525. doi: 10.1111/dom.14894. Epub 2022 Nov 2.

引用本文的文献

1
Preoperative Factors Associated With Falls Following Total Hip Arthroplasty in Older Adults.老年患者全髋关节置换术后跌倒的术前相关因素
ACR Open Rheumatol. 2025 Sep;7(9):e70091. doi: 10.1002/acr2.70091.
2
"PrevenganT2," a Culturally Responsive Family-Based Diabetes Prevention Intervention for Hispanic or Latino Adults at High Risk for Type 2 Diabetes: Protocol for a Proof-of-Concept Evaluation.“PrevenganT2”,一项针对2型糖尿病高危西班牙裔或拉丁裔成年人的具有文化适应性的家庭糖尿病预防干预措施:概念验证评估方案
JMIR Res Protoc. 2025 Aug 14;14:e66317. doi: 10.2196/66317.
3
Behavioral and demographic associations of optimal glycemic control among patients with type 2 diabetes mellitus in Sri Lanka: a multicenter study.

本文引用的文献

1
Trends in Undiagnosed Diabetes Mellitus Among United States Adults: Cross-Sectional Analyses from NHANES 2011-2020.美国成年人未诊断糖尿病的趋势:2011 - 2020年美国国家健康与营养检查调查的横断面分析
Am J Cardiol. 2022 Jul 15;175:184-185. doi: 10.1016/j.amjcard.2022.04.032. Epub 2022 May 22.
2
Glycemic Control and Clinical Outcomes in U.S. Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database.美国新冠肺炎患者的血糖控制与临床结局:来自国家新冠肺炎队列协作组(N3C)数据库的数据
Diabetes Care. 2022 Feb 24;45(5):1099-106. doi: 10.2337/dc21-2186.
3
Demographic Variation in Health Insurance Coverage:United States, 2020.
斯里兰卡2型糖尿病患者最佳血糖控制的行为和人口统计学关联:一项多中心研究。
BMC Endocr Disord. 2025 Jul 14;25(1):178. doi: 10.1186/s12902-025-01994-1.
4
Social and Structural Determinants of Lower Extremity Amputations in Diabetes.糖尿病患者下肢截肢的社会和结构决定因素
Curr Diab Rep. 2025 Jul 2;25(1):40. doi: 10.1007/s11892-025-01598-y.
5
Race, diabetes, and cognitive function: a cross-sectional analysis of intersecting disparities in the NHANES cohort.种族、糖尿病与认知功能:美国国家健康与营养检查调查队列中交叉差异的横断面分析
Front Neurosci. 2025 May 6;19:1550077. doi: 10.3389/fnins.2025.1550077. eCollection 2025.
6
A Two-Way Text Messaging Intervention to Narrow Disparities in Patients With Type 2 Diabetes and Poor Glycemic Control.一项缩小2型糖尿病和血糖控制不佳患者差距的双向短信干预措施。
Diabetes Spectr. 2025 Jan 21;38(2):190-193. doi: 10.2337/ds24-0034. eCollection 2025 Spring.
7
Disparities in Diabetes in Pregnancy and the Role of Social Determinants of Health.孕期糖尿病的差异及健康的社会决定因素的作用。
Curr Diab Rep. 2025 May 14;25(1):33. doi: 10.1007/s11892-025-01587-1.
8
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: A Scoping Review.针对存在健康差异人群中患有多种慢性病患者的医疗保健模式:一项范围综述
J Gen Intern Med. 2025 Apr 23. doi: 10.1007/s11606-025-09491-w.
9
Evidence-Based Practice in Prescribing SGLT2i and GLP-1 RA Across Ethnic and Racial Groups: a Systematic Review and Meta-analysis of Observational Studies.跨种族和民族群体开具钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)和胰高血糖素样肽-1受体激动剂(GLP-1 RA)的循证实践:观察性研究的系统评价和荟萃分析
J Racial Ethn Health Disparities. 2025 Apr 21. doi: 10.1007/s40615-025-02410-z.
10
Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services.结构因素及其对新型抗糖尿病药物使用的影响:提高对临床药学服务的认识并增加其可及性的理由
J Am Coll Clin Pharm. 2025 Jan;8(1):47-51. doi: 10.1002/jac5.2050. Epub 2024 Nov 28.
2020年美国医疗保险覆盖情况的人口统计学差异
Natl Health Stat Report. 2022 Feb(169):1-15.
4
Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018.1999 - 2018年美国成年人糖尿病患病率及糖尿病危险因素控制趋势
JAMA. 2021 Jun 25;326(8):1-13. doi: 10.1001/jama.2021.9883.
5
Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018.美国成年人糖尿病治疗和控制的趋势,1999-2018 年。
N Engl J Med. 2021 Jun 10;384(23):2219-2228. doi: 10.1056/NEJMsa2032271.
6
Social Determinants of Health and Structural Inequities-Root Causes of Diabetes Disparities.健康的社会决定因素与结构性不平等——糖尿病差异的根本原因。
Diabetes Care. 2021 Jan;44(1):11-13. doi: 10.2337/dci20-0060.
7
Missing Data in Clinical Research: A Tutorial on Multiple Imputation.临床研究中的缺失数据:多重插补方法教程。
Can J Cardiol. 2021 Sep;37(9):1322-1331. doi: 10.1016/j.cjca.2020.11.010. Epub 2020 Dec 1.
8
Social Determinants of Poor Management of Type 2 Diabetes Among the Insured.社会决定因素对参保人群 2 型糖尿病管理不善的影响。
Curr Diab Rep. 2020 Nov 5;20(11):67. doi: 10.1007/s11892-020-01354-4.
9
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity.腰围作为临床实践中的生命体征:IAS 和 ICCR 内脏肥胖工作组的共识声明。
Nat Rev Endocrinol. 2020 Mar;16(3):177-189. doi: 10.1038/s41574-019-0310-7. Epub 2020 Feb 4.
10
Change in Insurance Status and Cost-related Medication Non-adherence among Older U.S. Adults with Diabetes from 2010 to 2014.2010年至2014年美国老年糖尿病患者保险状况变化及与费用相关的药物治疗不依从情况
J Health Med Econ. 2018;4(2). doi: 10.21767/2471-9927.100040.